Evidence map›Paper›PMID 33775998›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports.

Aya Watanabe, Masayuki Shiseki, Megumi Oishi, Maya Kobayashi, Shoko Oshima, Satoko Osanai, Michiko Ryuzaki, Yuki Izuka, Norina Tanaka, Midori Ishiyama and 5 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Aya WatanabeDepartment of Hematology, Tokyo Women's Medical University, Japan.
Masayuki ShisekiDepartment of Hematology, Tokyo Women's Medical University, Japan.
Megumi OishiDepartment of Hematology, Tokyo Women's Medical University, Japan.
Maya KobayashiDepartment of Hematology, Tokyo Women's Medical University, Japan.
Shoko OshimaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Satoko OsanaiDepartment of Hematology, Tokyo Women's Medical University, Japan.
Michiko RyuzakiDepartment of Hematology, Tokyo Women's Medical University, Japan.
Yuki IzukaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Norina TanakaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Midori IshiyamaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Akihito ShinoharaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Hiroshi KazamaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Shotaro HagiwaraDepartment of Hematology, Tokyo Women's Medical University, Japan.
Kentaro YoshinagaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Junji TanakaDepartment of Hematology, Tokyo Women's Medical University, Japan.
Tokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report two cases of thrombotic thrombocytopenic purpura (TTP) complicated by other autoimmune disorders, autoimmune hepatitis and immune thrombocytopenia, respectively. In both cases, corticosteroids were continuously administered for the treatment of preceding autoimmune disorders. However, a sufficient objective response for TTP was not obtained by plasma exchange and corticosteroid treatment. Once a week rituximab (375 mg/m

Indexed as

Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic ThrombocytopenicHumansPlasma ExchangeRecurrenceRituximabRituximabADAMTS13autoimmune hepatitisimmune thrombocytopeniarituximabthrombotic thrombocytopenic purpura

Identifiers

PMID33775998
PMCPMC8479212
OpenAlexW3150021526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.